{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T02:42:57Z","timestamp":1776652977232,"version":"3.51.2"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00415-026-13668-6","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:59:16Z","timestamp":1775523556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MOGAD update: new phenotypes in the expanding clinical spectrum"],"prefix":"10.1007","volume":"273","author":[{"given":"F.","family":"Costello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"13668_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00431-8","author":"B Banwell","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP et al (2023) Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(22)00431-8","journal-title":"Lancet Neurol"},{"issue":"8","key":"13668_CR2","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1007\/s00415-023-11737-8","volume":"270","author":"A Al Ani","year":"2023","unstructured":"Al Ani A, Chen J, Costello F (2023) Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges. J Neurol 270(8):4132\u20134150. https:\/\/doi.org\/10.1007\/s00415-023-11737-8","journal-title":"J Neurol"},{"key":"13668_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1260358","volume":"14","author":"JY Hor","year":"2023","unstructured":"Hor JY, Fujihara K (2023) Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide. Front Neurol 14:1260358. https:\/\/doi.org\/10.3389\/fneur.2023.1260358","journal-title":"Front Neurol"},{"issue":"10","key":"13668_CR4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213557","volume":"104","author":"A Dinoto","year":"2025","unstructured":"Dinoto A, Cacciaguerra L, Vorasoot N, Redenbaugh V, Lopez-Chiriboga SA, Valencia-Sanchez C et al (2025) Clinical features and factors associated with outcome in late adult-onset myelin oligodendrocyte glycoprotein antibody-associated disease. Neurology 104(10):e213557. https:\/\/doi.org\/10.1212\/WNL.0000000000213557","journal-title":"Neurology"},{"issue":"7","key":"13668_CR5","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1136\/jnnp-2024-334613","volume":"96","author":"Y Fan","year":"2025","unstructured":"Fan Y, Wang Z, Wu Y, Zhou L, Wang L, Huang W, Tan H, Chang X, ZhangBao J, Quan C (2025) Fewer relapses and worse outcomes of patients with late-onset myelin oligodendrocyte glycoprotein antibody-associated disease. J Neurol Neurosurg Psychiatry 96(7):655\u2013664. https:\/\/doi.org\/10.1136\/jnnp-2024-334613","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3_suppl","key":"13668_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/13524585251358344","volume":"31","author":"R Cortese","year":"2025","unstructured":"Cortese R, Cagol A, de Mauro A, Bianchi A, Amato MP, Anderhalten U et al (2025) Evaluating PIRA, PIRMA, and non-motor disability progression in MOGAD and AQP4+NMOSD. ECTRIMS 2025 Paper Poster Session 1 and 2. Mult Scler J 31(3_suppl):136\u2013762. https:\/\/doi.org\/10.1177\/13524585251358344","journal-title":"Mult Scler J"},{"key":"13668_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.104436","volume":"69","author":"I Lotan","year":"2023","unstructured":"Lotan I, Billiet T, Ribbens A, Van Hecke W, Huang B, Kister I, Lotan E (2023) Volumetric brain changes in MOGAD: a cross-sectional and longitudinal comparative analysis. Mult Scler Relat Disord 69:104436. https:\/\/doi.org\/10.1016\/j.msard.2022.104436","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"13668_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ana.26951","volume":"96","author":"R Cortese","year":"2024","unstructured":"Cortese R, Battaglini M, Prados F, Gentile G, Luchetti L, Bianchi A, MAGNIMS Study Group et al (2024) Grey matter atrophy and its relationship with white matter lesions in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder, and multiple sclerosis. Ann Neurol 96(2):276\u2013288. https:\/\/doi.org\/10.1002\/ana.26951","journal-title":"Ann Neurol"},{"issue":"3_suppl","key":"13668_CR9","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1177\/13524585251370543","volume":"31","author":"DM Wingerchuk","year":"2025","unstructured":"Wingerchuk DM, Marignier R, Palace J, Paul F, Aktas O, Bennet JL et al (2025) IPND 2025: Revised consensus criteria, classification, and nomenclature for neuromyelitis optica spectrum disorders Late Breaking Poster P427. Mult Scler J 31(3_suppl):1342\u20131390. https:\/\/doi.org\/10.1177\/13524585251370543","journal-title":"Mult Scler J"},{"key":"13668_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.101965","volume":"40","author":"S Asseyer","year":"2020","unstructured":"Asseyer S, Hamblin J, Messina S, Mariano R, Siebert N, Everett R et al (2020) Prodromal headache in MOG-antibody positive optic neuritis. Mult Scler Relat Disord 40:101965. https:\/\/doi.org\/10.1016\/j.msard.2020.101965","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"13668_CR11","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1111\/ene.14729","volume":"28","author":"S Asseyer","year":"2021","unstructured":"Asseyer S, Henke E, Trebst C, H\u00fcmmert MW, Wildemann B, Jarius S, Neuromyelitis Optica Study Group et al (2021) Pain, depression, and quality of life in adults with MOG-antibody-associated disease. Eur J Neurol 28(5):1645\u20131658. https:\/\/doi.org\/10.1111\/ene.14729","journal-title":"Eur J Neurol"},{"issue":"1","key":"13668_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1212\/CON.0000000000001390","volume":"30","author":"CA Pardo","year":"2024","unstructured":"Pardo CA (2024) Clinical approach to myelopathy diagnosis. Continuum 30(1):14\u201352. https:\/\/doi.org\/10.1212\/CON.0000000000001390","journal-title":"Continuum"},{"issue":"2","key":"13668_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/1352458520907900","volume":"27","author":"E Sechi","year":"2021","unstructured":"Sechi E, Krecke KN, Pittock SJ, Dubey D, Lopez-Chiriboga AS, Kunchok A et al (2021) Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies. Mult Scler 27(2):303\u2013308. https:\/\/doi.org\/10.1177\/1352458520907900","journal-title":"Mult Scler"},{"issue":"10","key":"13668_CR14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209303","volume":"102","author":"L Cacciaguerra","year":"2024","unstructured":"Cacciaguerra L, Abdel-Mannan O, Champsas D, Mankad K, Krecke KN, Chen JJ et al (2024) Radiologic lag and brain MRI lesion dynamics during attacks in MOG antibody-associated disease. Neurology 102(10):e209303. https:\/\/doi.org\/10.1212\/WNL.0000000000209303","journal-title":"Neurology"},{"issue":"1","key":"13668_CR15","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200174","volume":"11","author":"L Nguyen","year":"2023","unstructured":"Nguyen L, Miles DK, Harder L, Singh S, Whittemore BA, Greenberg BM, Wang CX (2023) Increased intracranial pressure in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease. Neurol Neuroimmunol Neuroinflamm 11(1):e200174. https:\/\/doi.org\/10.1212\/NXI.0000000000200174","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"11","key":"13668_CR16","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1001\/jamaneurol.2024.2945","volume":"81","author":"N Tisavipat","year":"2024","unstructured":"Tisavipat N, Rattanathamsakul N, Salman A et al (2024) Intracranial pressure elevation and MOGAD. JAMA Neurol 81(11):1226\u20131228. https:\/\/doi.org\/10.1001\/jamaneurol.2024.2945","journal-title":"JAMA Neurol"},{"key":"13668_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2023.107778","volume":"231","author":"Z Ma","year":"2023","unstructured":"Ma Z, Jiang H, Wang J (2023) Enhancement of optic nerve sheath on MRI in idiopathic intracranial hypertension (IIH). Clin Neurol Neurosurg 231:107778. https:\/\/doi.org\/10.1016\/j.clineuro.2023.107778","journal-title":"Clin Neurol Neurosurg"},{"issue":"5","key":"13668_CR18","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200275","volume":"11","author":"CE Moseley","year":"2024","unstructured":"Moseley CE, Virupakshaiah A, Forsthuber TG, Steinman L, Waubant E, Zamvil SS (2024) MOG CNS autoimmunity and MOGAD. Neurol Neuroimmunol Neuroinflamm 11(5):e200275. https:\/\/doi.org\/10.1212\/NXI.0000000000200275","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"13668_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/20552173221148911","volume":"9","author":"C Azar","year":"2023","unstructured":"Azar C, Akiki G, Haddad SF, Kerbage A, Haddad F, Macaron G (2023) High fever in myelin oligodendrocyte glycoprotein-associated disorder (MOGAD): a diagnostic challenge. Mult Scler J Exp Transl Clin 9(1):20552173221148911. https:\/\/doi.org\/10.1177\/20552173221148911","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"13668_CR20","doi-asserted-by":"publisher","first-page":"102748","DOI":"10.1016\/j.msard.2021.102748","volume":"49","author":"A Lampros","year":"2021","unstructured":"Lampros A, De Broucker T, Bonnan M (2021) Fever is a common onset feature of MOG-IgG associated disorders (MOGAD). Mult Scler Relat Disord 49:102748","journal-title":"Mult Scler Relat Disord"},{"issue":"9","key":"13668_CR21","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1177\/13524585221090737","volume":"28","author":"E Gibbons","year":"2022","unstructured":"Gibbons E, Whittam D, Elhadd K, Bhojak M, Rathi N, Avula S, Jacob A, Griffiths M, Huda S (2022) Progressive myelin oligodendrocyte glycoprotein-associated demyelination mimicking leukodystrophy. Mult Scler 28(9):1481\u20131484. https:\/\/doi.org\/10.1177\/13524585221090737","journal-title":"Mult Scler"},{"issue":"1","key":"13668_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.55697\/tnd.2025.149","volume":"31","author":"N Sinha","year":"2025","unstructured":"Sinha N, Prakash P, Ranjan A (2025) Chronic progressive behavioral changes associated with headache: an atypical presentation of myelin oligodendrocyte glycoprotein (MOG)-associated disease. Turk J Neurol 31(1):76\u201379. https:\/\/doi.org\/10.55697\/tnd.2025.149","journal-title":"Turk J Neurol"},{"issue":"18_supplement","key":"13668_CR23","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.98.18_supplement.2429","volume":"98","author":"D Anson","year":"2022","unstructured":"Anson D, Sudha AP, Bartnik N, Patel A (2022) MOG antibody associated-disease manifesting as MRI-negative encephalitis: a case report and literature review (P16-1.004). Neurology 98(18_supplement):2429. https:\/\/doi.org\/10.1212\/WNL.98.18_supplement.2429","journal-title":"Neurology"},{"issue":"4","key":"13668_CR24","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3988\/jcn.2022.0433","volume":"19","author":"J Hwangbo","year":"2023","unstructured":"Hwangbo J, Oh SI (2023) A case of MRI-negative encephalomyelitis in a patient with long-term stable myelin oligodendrocyte glycoprotein antibody-associated disease. J Clin Neurol 19(4):422\u2013424. https:\/\/doi.org\/10.3988\/jcn.2022.0433","journal-title":"J Clin Neurol"},{"issue":"19","key":"13668_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13193148","volume":"13","author":"S Kim","year":"2023","unstructured":"Kim S, Eun MY, Lee JJ, Seok HY (2023) Acute hemorrhagic encephalomyelitis in the context of MOG antibody-associated disease. Comment on Chen et al. rapid progressive fatal acute hemorrhagic encephalomyelitis. Diagnostics 13(19):2481. https:\/\/doi.org\/10.3390\/diagnostics13193148","journal-title":"Diagnostics"},{"issue":"7","key":"13668_CR26","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1136\/jnnp-2023-331350","volume":"94","author":"L Skarsta","year":"2023","unstructured":"Skarsta L, Nicoletti T, Frick K et al (2023) Acute haemorrhagic leucoencephalitis as clinical manifestation of MOG antibody-associated\u00a0disease. J Neurol Neurosurg Psychiatry 94(7):583\u2013585","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"13668_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e30633","volume":"10","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhangbao J, Xu J, Zhou L, Zhou Z, Quan C (2024) The distinction of area postrema syndrome between MOGAD and NMOSD. Heliyon 10(10):e30633. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30633","journal-title":"Heliyon"},{"key":"13668_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-325121","volume":"92","author":"SA Banks","year":"2020","unstructured":"Banks SA, Morris PP, Chen JJ, Pittock SJ, Sechi E, Kunchok A, Tillema JM, Fryer JP, Weinshenker BG, Krecke KN, Lopez-Chiriboga AS, Nguyen A, Greenwood TM, Lucchinetti CF, Zalewski NL, Messina SA, Flanagan EP (2020) Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS. J Neurol Neurosurg Psychiatry 92:jnnp-2020-325121. https:\/\/doi.org\/10.1136\/jnnp-2020-325121","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"13668_CR29","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1038\/s41433-024-03108-y","volume":"38","author":"N Jeyakumar","year":"2024","unstructured":"Jeyakumar N, Lerch M, Dale RC, Ramanathan S (2024) MOG antibody-associated optic neuritis. Eye Lond 38(12):2289\u20132301. https:\/\/doi.org\/10.1038\/s41433-024-03108-y","journal-title":"Eye Lond"},{"issue":"9","key":"13668_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2025-267238","volume":"18","author":"BS Kamath","year":"2025","unstructured":"Kamath BS, Charlotte A, Dsouza J, Duble S (2025) Atypical presentation of MOGAD-associated optic neuritis with premacular haemorrhage. BMJ Case Rep 18(9):e267238. https:\/\/doi.org\/10.1136\/bcr-2025-267238","journal-title":"BMJ Case Rep"},{"issue":"3","key":"13668_CR31","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1080\/01658107.2023.2290540","volume":"48","author":"GA Wilke","year":"2024","unstructured":"Wilke GA, Spencer M, Gilman CA, Guerriero R, Bohm P, Van Stavern GP, Lee AR (2024) Peripheral retinal haemorrhages in a patient with MOG-associated optic neuritis. Neuroophthalmology 48(3):176\u2013182. https:\/\/doi.org\/10.1080\/01658107.2023.2290540","journal-title":"Neuroophthalmology"},{"key":"13668_CR32","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000208847","author":"N Tisavipat","year":"2025","unstructured":"Tisavipat N, Rattanathamsakul N, Lang M, Welk G et al (2025) The frequency of optic disc hemorrhages and other retinal findings on fundoscopic examination in acute MOGAD optic neuritis (P11-8.005). Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000208847","journal-title":"Neurology"},{"issue":"1","key":"13668_CR33","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1097\/WNO.0000000000001400","volume":"42","author":"VD Liou","year":"2022","unstructured":"Liou VD, Yoon MK, Maher M, Chwalisz BK (2022) Orbital inflammation in myelin oligodendrocyte glycoprotein antibody-associated disease: a case report and review of the literature. J Neuroophthalmol 42(1):e56\u2013e62. https:\/\/doi.org\/10.1097\/WNO.0000000000001400","journal-title":"J Neuroophthalmol"},{"key":"13668_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/pn-2022-003560","volume":"23","author":"M Nasir","year":"2023","unstructured":"Nasir M, Obrocki R, Magda K, Naveed M (2023) Conus medullaris syndrome as a presenting feature of MOG-associated disease. Pract Neurol 23:10.1136\/pn-2022-003560","journal-title":"Pract Neurol"},{"key":"13668_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s43055-023-01126-6","volume":"54","author":"A Nerlekar","year":"2023","unstructured":"Nerlekar A, Malvadkar S, Patil D et al (2023) A rare presentation of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) as acute hemorrhagic longitudinally extensive transverse myelitis. Egypt J Radiol Nucl Med 54:189. https:\/\/doi.org\/10.1186\/s43055-023-01126-6","journal-title":"Egypt J Radiol Nucl Med"},{"key":"13668_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.993645","volume":"13","author":"L Cacciaguerra","year":"2022","unstructured":"Cacciaguerra L, Sechi E, Rocca MA, Filippi M, Pittock SJ, Flanagan EP (2022) Neuroimaging features in inflammatory myelopathies: a review. Front Neurol 13:993645. https:\/\/doi.org\/10.3389\/fneur.2022.993645","journal-title":"Front Neurol"},{"issue":"11","key":"13668_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12111529","volume":"12","author":"Y Du","year":"2022","unstructured":"Du Y, Xiao L, Ding Z, Huang K, Xiao B, Feng L (2022) MOGAD involving cranial neuropathies: a case report and review of literature. Brain Sci 12(11):1529. https:\/\/doi.org\/10.3390\/brainsci12111529","journal-title":"Brain Sci"},{"issue":"1","key":"13668_CR38","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000924","volume":"8","author":"S Rinaldi","year":"2020","unstructured":"Rinaldi S, Davies A, Fehmi J, Beadnall HN, Wang J, Hardy TA, Barnett MH, Broadley SA, Waters P, Reddel SW, Irani SR, Brilot F, Dale RC, Ramanathan S, Australian and New Zealand MOG Study Group (2020) Overlapping central and peripheral nervous system syndromes in MOG antibody-associated disorders. Neurol Neuroimmunol Neuroinflamm 8(1):e924. https:\/\/doi.org\/10.1212\/NXI.0000000000000924","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"13668_CR39","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/acn3.52001","volume":"11","author":"P Gupta","year":"2024","unstructured":"Gupta P, Paul P, Redenbaugh V, Guo Y, Lucchinetti C, Abdulrahman Y, Datta A, Shah S, Klein CJ, Pittock SJ, Flanagan EP, Dubey D (2024) Peripheral nervous system manifestations of MOG antibody associated disease. Ann Clin Transl Neurol 11(4):1046\u20131052. https:\/\/doi.org\/10.1002\/acn3.52001","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"13668_CR40","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/jamaneurol.2021.0912","volume":"78","author":"E Sechi","year":"2021","unstructured":"Sechi E, Buciuc M, Pittock SJ et al (2021) Positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing. JAMA Neurol 78(6):741\u2013746. https:\/\/doi.org\/10.1001\/jamaneurol.2021.0912","journal-title":"JAMA Neurol"},{"issue":"1","key":"13668_CR41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/ana.26931","volume":"96","author":"V Redenbaugh","year":"2024","unstructured":"Redenbaugh V, Fryer JP, Cacciaguerra L et al (2024) Diagnostic utility of MOG antibody testing in cerebrospinal fluid. Ann Neurol 96(1):34\u201345. https:\/\/doi.org\/10.1002\/ana.26931","journal-title":"Ann Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13668-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13668-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13668-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T01:48:21Z","timestamp":1776649701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13668-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["13668"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13668-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest with the content of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"252"}}